Pulmicort and Ischaemic stroke - a phase IV clinical study of FDA data

Summary:

Ischaemic stroke is reported as a side effect among people who take Pulmicort (budesonide), especially for people who are female, 60+ old, also take Allegra, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Ischaemic stroke when taking Pulmicort. It is created by eHealthMe based on reports of 34,552 people who have side effects when taking Pulmicort from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Ischaemic stroke?

Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain) is found to be associated with 848 drugs and 1,095 conditions by eHealthMe. Check the latest studies of Ischaemic stroke.

On Jul, 29, 2026

34,552 people reported to have side effects when taking Pulmicort.
Among them, 21 people (0.06%) have Ischaemic stroke.

Among these 21 people:

What is the gender of people who have Ischaemic stroke when taking Pulmicort? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Ischaemic stroke when taking Pulmicort? *

What are other drugs people take besides Pulmicort? *

What are other side effects people have besides Ischaemic stroke? *

Anaemia (lack of blood): 6 people, 28.57%
Weight Decreased: 4 people, 19.05%
Pain In Extremity: 4 people, 19.05%
Traumatic Injury Of The Bladder And Urethra: 3 people, 14.29%
Joint Swelling: 3 people, 14.29%
Hypersensitivity: 3 people, 14.29%
Neck Pain: 3 people, 14.29%
Ecchymosis (a discoloration of the skin resulting from bleeding underneath): 3 people, 14.29%
Endometrial Cancer: 2 people, 9.52%
Hypotension (abnormally low blood pressure): 2 people, 9.52%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 33.33%
Pulmonary Sarcoidosis (growth of tiny collections of inflammatory cells in lungs): 4 people, 19.05%
High Blood Pressure: 3 people, 14.29%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 14.29%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 9.52%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 9.52%
Prostate Cancer: 1 person, 4.76%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 4.76%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 4.76%
Adverse Event: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Ischaemic stroke?

- Check whether Ischaemic stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort:

Pulmicort (34,980 reports)

Ischaemic stroke treatments and more:

Ischaemic stroke (25,786 reports)

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ischaemic stroke:

Ischaemic stroke (848 drugs)

Browse all the conditions that are associated with Ischaemic stroke:

Ischaemic stroke (1,095 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort) and Pulmicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.